Omnipaque™ (iohexol)

The only low-osmolar contrast medium (LOCM) listed in the WHO (World Health Organisation) essential drug list1 and used in over 600 million procedures2

Fast Facts

  • IV
  • search
  • preview-eyeball
  • Patient after patient

    Omnipaque gives you reliability and choice

    • Indicated for intravenous, intra-arterial, body cavity, intrathecal and oral uses3
    • Approved for use in both adults and children3

    Omnipaque is indicated for oral use:

    Palatability
    It has been shown that the administration of oral contrast medium is the least pleasant part of the patient computed tomography (CT) experience4

    • If a contrast medium for oral use is not unpleasant to taste, patients are more likely to be able to drink the volume required4
    • 81% of adult body CT patients, who expressed a preference, preferred Omnipaque over diatrizoate4 Omnipaque diluted with water came top in the taste test of various contrast media5
    • 98% of pediatric patients undergoing abdominal CT, many of whom under the age of 5, drank the required volume of diluted Omnipaque6

    Usability
    Hypertonic agents draw fluid from the plasma and interstitium into the bowel, resulting in progressive loss of radiocontrast through dilution as the agent travels through the gut5,6

    • Omnipaque provided better contrast density than sodium diatrizoate in adults with suspected intestinal obstruction7
    • Omnipaque is well suited for visualisation of intestinal loops and provided for good quality scans in children of all ages6,9,10

    References:
    1. WHO Model List of Essential Medicines, 19th list, April 2015. Available at: https://www.who.int/medicines/publications/essentialmedicines/en/. Accessed on 17 March 2017.
    2. Data on File, GE Healthcare, 2017.
    3. Omnipaque Summary of Product Characteristics, June 2016.
    4. McNamara M et al. Am J Roentgenol 2010; 195: 1137–41.
    5. Diederichs G et al. Fortschr Röntgenstr 2007; 179: 1061–7.
    6. Smevik B, Westvik J. Acta Radiol 1990; 31: 601–4.
    7. Jobling C et al. Eur Radiol 1999; 9: 706–10.
    8. Stordahl A et al. Acta Radiol 1988; 29: 53–6.
    9. Stake G, Smevik B. In: Kaufmann HJ, ed. Contrast Media in Child Radiology. Basel, Switzerland: Karger; 1986; 107–9.
    10. Smevik B, Stake G. In: Kaufmann HJ, ed. Contrast Media in Child Radiology. Basel, Switzerland: Karger; 1986; 79–80

  • Scan after scan

    Supporting patient throughput with Omnipaque 500ml capacity1

    Omnipaque 500ml can be used for up to 24 hours from initial puncture
    Chemical and physical stability has been demonstrated for 24 hours at 25oC2



  • Attaching a new contrast bottle takes 32 seconds1

    a total saving of 199 hours of radiographic time each year in Sheffield with the Omnipaque 500ml bottle1



    References:
    1. Sugden D. Presented at UK North CT Radiographer Workshop. Leeds,March 2017.
    2. Omnipaque Summary of Product Characteristics.September 2018.

  • Interruption after interruption

    Omnipaque’s unique +PLUSPAKTM packaging enhances user handling and workplace safety.

    +PLUSPAK™ has no sharp alloy ring pull

    • Easy-open polypropylene ring pull avoids cuts from sharp metal edges3
    • Packaging removes risk of injuries from glass breakages3

    +PLUSPAKTM has efficient labelling

    • Important information is repeated upside down for dual-direction reading
    • Colour-coded for concentration for easy recognition

    +PLUSPAKTM reduces costs and environmental impact

    • Less storage space, lower disposal costs, reduced environmental impact3,4

    *Concentrations, volumes and packaging vary from country to country

    References:
    1. WHO Model List of Essential Medicines, 19th list, April 2015. Available at: https://www.who.int/medicines/publications/essentialmedicines/en/. Accessed on 17 March 2017.
    2. Data on File, GE Healthcare, 2017.
    3. Gricar J et al. Radiol Manage 2007; SEP/OCT: 34–42.
    4. Marshall G. Radiography 2008; 14: 128-34

Prescribing Information

  1. WHO Model List of Essential Medicines, 20th List, August 2017
  2. Data on File, GE Healthcare_Usage
  3. Smevik B, Westvik J. Acta Radiol 1990; 31(6): 601-4.
  4. Gomi T et al. Eur Radiol 2010; 20(7): 1631-5.
  5. Omnipaque Summary of Product Characteristics, July 2016
  6. Marshall G. Radiography 2008; 14: 128-34.
  7. Gricar J et al. Radiol Manage 2007; SEP/OCT: 34-42.
  8. Dhaliwal H et al. Int J Life Cycle Assess 2014; 19: 1965-73.